Clinical Trial Details

Trial ID: L0923
Source ID: NCT01792115
Associated Drug: Vitamin E
Title: Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Acronym: --
Status: Not recruiting
Study Results: Has Results
Results: https://clinicaltrials.gov/ct2/show/results/NCT01792115
Conditions: Fatty Liver
Interventions: Drug: Vitamin E 200 IU/d;Drug: Vitamin E 400 IU/d;Drug: Vitamin E 800 IU/d;Behavioral: Diet and Exercise
Outcome Measures: Biochemical: Number of Patients With Normal Transaminases at End of Treatment.;Physiological: Absolute Change in Liver FatAbsolute Change in AST;Percent Change in AST;Absolute Change in ALT;Percent Change in ALT;Absolute Change in GGT;Percent Change in Liver Fat
Sponsor/Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Gender: All
Age: 18 Yearsnan
Phases: Phase 2
Enrollment: 22
Study Type: Interventional
Study Designs: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Start Date: 13/02/2013
Completion Date: --
Results First Posted: 19/10/2020
Last Update Posted: 12 December 2020
Locations: United States
URL: https://clinicaltrials.gov/show/NCT01792115